{"altmetric_id":3648431,"counts":{"readers":{"mendeley":0,"citeulike":0,"connotea":0},"total":{"posts_count":1},"wikipedia":{"unique_users_count":1,"unique_users":["en:35796613"],"posts_count":1}},"citation":{"doi":"10.5772\/30377","first_seen_on":"2015-02-15T04:08:48+00:00","issns":["978-953-51-0237-3"],"last_mentioned_on":1336813820,"links":["http:\/\/dx.doi.org\/10.5772\/30377"],"pdf_url":"http:\/\/www.intechopen.com\/books\/constipation-causes-diagnosis-and-treatment\/opioid-induced-constipation","title":"Drugs in Development for Opioid-Induced Constipation","type":"article"},"altmetric_score":{"score":3,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":3},"context_for_score":null},"demographics":[],"posts":{"wikipedia":[{"title":"Naldemedine","url":"http:\/\/en.wikipedia.org\/?diff=prev&oldid=492173922#altmetric_citation_0","license":"public","citation_ids":[3648431],"posted_on":"2012-05-12T09:10:20+00:00","summary":"Naldemedine (INN, USAN; S-297,995) is a peripherally-selective \u03bc-opioid receptor antagonist under development by Shionogi for the treatment of opioid-induced adverse effects including constipation, nausea, and vomiting.","page_url":"http:\/\/en.wikipedia.org\/?curid=35796613","wiki_lang":"en","author":{"name":"Vanished 45kd09la13","url":"http:\/\/en.wikipedia.org\/wiki\/User:Vanished 45kd09la13"}}]}}